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We describe the first case of Bartonella quintana endocarditis
affecting a prosthetic valve in a person with no known risk fac-
tors for this infection. Bartonella should be considered as a
cause of endocarditis in any clinical setting.
our species of Bartonella have been described as a cause
of endocarditis in humans: Bartonella quintana, B. hense-
lae, B. elizabethae, and B. vinsonii subsp. berkhoffii. Although
infection with the latter two species has been reported only as
single cases, endocarditis caused by B. quintana and B. hense-
lae has been increasingly recognized in recent years. Most
cases in which B. quintana has been implicated as the infect-
ing species (usually through culture or molecular techniques)
have had known risk factors such as homelessness, alcohol-
ism, or human HIV infection (1-3). We report a case of B.
quintana endocarditis affecting a prosthetic valve in a person
with no known risk factors.
Case Report
A 46-year-old Indian woman, who had lived in the United
Kingdom for 10 years, was admitted to our hospital in June
2000 with a 3-month history of fever, sweats, and rigors asso-
ciated with anorexia and 5-kg weight loss. Medical history
included prosthetic aortic valve insertion in 1992 for aortic
stenosis. In 1998, the patient had a hemorrhagic cerebrovascu-
lar event, a presumed consequence of anticoagulation therapy
with warfarin. In October 1999, she was admitted to another
hospital with fever, anemia, renal impairment, hypergamma-
globulinemia, and microscopic hematuria. Several days later,
she had sudden loss of vision due to a large right-sided occipi-
tal hemorrhage that required surgical evacuation. A trans-
esophageal echocardiogram at that stage revealed no evidence
of endocarditis, and three blood cultures were sterile. The
patient was unemployed and lived with her father. She did not
smoke or drink alcohol and actively disliked and had no con-
tact with animals.
The patient was clinically anemic, had no fever, and had
several subconjunctival hemorrhages. There was no evidence
of ectoparasite infestation. Cardiovascular examination
showed a water-hammer pulse (Corrigan’s sign), prosthetic
heart sounds, an ejection systolic murmur, and an early dias-
tolic murmur consistent with aortic regurgitation. Respiratory
examination was unremarkable, and splenomegaly (1-cm
enlargement) was detected in the abdomen. Residual left hemi-
paresis and hemianopia, resulting from her previous cere-
brovascular accidents, were present. 
Urinalysis showed proteinuria and hematuria; urinary pro-
tein excretion was measured at 2.54 g/L. The patient was ane-
mic, with a hemoglobin of 7.2 g/dL with normal leukocyte and
platelet counts. The serum creatinine was elevated at 168
µmol/L, and serum globulins were increased with low serum
albumin (27 g/dL). The C-reactive protein was elevated at 66
g/dL. Six blood cultures were sterile, and an HIV antibody test
result was negative. A transthoracic echocardiogram was unre-
markable, but a transesophageal study showed two 1.5-cm
vegetations attached to the prosthetic aortic valve, with moder-
ate paravalvular regurgitation. A diagnosis of culture-negative
endocarditis was made, antibiotic treatment with vancomycin
and gentamicin was commenced, and the patient was referred
for surgical assessment. 
Despite antibiotic therapy, fever, progressive renal impair-
ment (serum creatinine 300 µmol/L), and leukopenia devel-
oped. In view of the valvular pathology, the aortic valve
prosthesis was replaced with a homograft root into which the
coronary arteries were reimplanted. Microbiologic examina-
tion of the excised valve showed no organisms on Gram stain
and no bacteriologic growth. There was insufficient material
for histologic examination.
During screening for rarer causes of endocarditis, Chlamy-
dia serology was found to be positive, with Chlamydia tra-
chomatis and C. pneumoniae immunoglobulin (Ig) G titers
>512 by microimmunofluorescence (MRL Diagnostics, Bind-
ing Site Ltd, UK). Bartonella serology was positive by immu-
nofluorescence, with IgG titers >8,192 for both B. henselae
and B. quintana and a positive IgM for both species (titer =80).
Genomic DNA was extracted from the vegetation removed at
surgery by using the QIAamp Tissue Kit (QIAGEN Ltd,
Crawley, UK). Two pairs of oligonucleotide primers were used
to amplify overlapping fragments of the 16S ribosomal DNA
(rDNA) gene. The first primer pair amplified a 296-bp seg-
ment of the Bartonella gene, as described (4). The second
primer pair (5'-GAAGGGGGCTAGCGTTGT-3' and 5'-
AACTGAGATGGCTTTTGGAG-3') was designed to amplify
a 768-bp fragment of the same gene in alpha-Proteobacteria
(5). DNA sequencing of both amplicons allowed analysis of a
720-bp fragment of the 16S rDNA gene. This sequence was
most closely related to the four B. quintana sequences depos-
ited in GenBank (0 to 3 nucleotide differences, corresponding
to 99.7% to 100% similarity). In contrast, the sequence had
nine nucleotide differences (98.8% similarity) from that of B.
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henselae, the next closest match, establishing B. quintana as
the infecting species in this case. 
A serum sample drawn in October 1999 was retrospec-
tively tested and also found to be positive for Bartonella IgG
and IgM antibodies. Initial postoperative therapy with teico-
planin and ceftriaxone (given for 1 week) was changed to
ciprofloxacin for a total of 1 month. Oral clarithromycin was
then given for another month. Six weeks after surgery, the
patient was afebrile, the valve was functioning satisfactorily,
and splenomegaly had resolved. Both the C-reactive protein
and serum creatinine had returned to normal.
Conclusions
This case report documents the first description to our
knowledge of B. quintana endocarditis affecting a prosthetic
valve; after surgical and medical therapy the outcome was
favorable.  The first descriptions of human disease caused by
B. quintana emerged during World War I (1914-1918), when
approximately 1 million cases of trench fever occurred (6).
Subsequently, the organism has been shown to be a cause of
bacillary angiomatosis in HIV-infected persons. More recently,
endocarditis and chronic bacteremic illness resembling trench
fever have been described, with affected persons usually being
homeless or alcoholic (6). The body louse was shown to be the
vector of trench fever and has been postulated as a vector of
contemporary B. quintana infection, although direct evidence
for this is lacking. Valve replacement has been the rule in the
few reported cases of Bartonella endocarditis. This surgical
intervention may reflect either a poor clinical response to med-
ical therapy or the fact that diagnostic delay, as in our case,
may lead to valve destruction to a degree that necessitates
valve replacement. 
An interesting aspect of our case is that none of the previ-
ously known risk factors for infection with B. quintana were
present. B. quintana native-valve endocarditis in persons with-
out recognized risk factors appears rare (7). Since clinicians
are only likely to investigate the possibility of this infection in
patients with known risk factors, reported cases may not accu-
rately reflect levels of Bartonella infection. Thus, as with any
emerging disease, the clinical and epidemiologic features of
contemporary  B. quintana infection remain to be fully
described. Using a large bank of control sera, Raoult et al. (1)
estimated that a Bartonella IgG titer >1,600 has a positive pre-
dictive value for endocarditis of 0.884. Detection of high-titer
Bartonella antibodies will therefore be a powerful diagnostic
tool in cases of suspected endocarditis; such results could have
established the diagnosis 8 months earlier for our patient.
In the recent study from Canada and France, Bartonella
was estimated to cause 3% of all cases of endocarditis (1). The
true incidence of Bartonella endocarditis in countries such as
the United States or the United Kingdom is unknown. Of 66
sera taken from cases of culture-negative endocarditis and sent
to the Public Health Laboratory Service in London, United
Kingdom, 18% were positive for Bartonella antibodies (8).
Although ascertainment bias may have increased this figure,
this organism is clearly an important cause of culture-negative
endocarditis in the United Kingdom (9). As in our case, cross-
reacting anti-chlamydial antibodies are frequently detected in
cases of confirmed Bartonella endocarditis (1), and identifying
such antibodies in the context of endocarditis should prompt a
search for Bartonella infection. We recommend that in the
diagnostic work-up of patients with suspected endocarditis,
Bartonella infection should be sought by serologic testing at
an early stage, regardless of the presence or absence of recog-
nized risk factors.
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